SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade

Published:2016-04-22 Issue:6 Volume:5 Page:e1169353
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Xue Wei,Metheringham Rachael L.,Brentville Victoria A.,Gunn Barbara,Symonds Peter,Yagita Hideo,Ramage Judith M.,Durrant Lindy G.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2016.1169353

Reference64 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

5. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro;Translational Cancer Research;2024-01

3. New approaches to vaccines for cancer;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity;Journal for ImmunoTherapy of Cancer;2023-10

5. Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment;Frontiers in Immunology;2023-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3